• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫吸附法清除重症心力衰竭患者心肌抑制 IgG3 自身抗体。

Complete elimination of cardiodepressant IgG3 autoantibodies by immunoadsorption in patients with severe heart failure.

机构信息

Department of Cardiology, Kitasato Institute Hospital, Kitasato University School of Medicine, Tokyo, Japan.

出版信息

Circ J. 2010 Jul;74(7):1372-8. doi: 10.1253/circj.cj-09-0748. Epub 2010 May 22.

DOI:10.1253/circj.cj-09-0748
PMID:20501959
Abstract

BACKGROUND

Cardiodepressant IgG3 autoantibodies (CD-Abs) can be targeted by apheresis. Using blinded measurements of CD-Abs before and after immunoadsorption (IA), the cardiac function of patients who did or did not achieve complete CD-Abs elimination was compared.

METHODS AND RESULTS

Autoantibodies were completely removed from 18 patients with heart failure (New York Heart Association class 3 or 4, left ventricular ejection fraction (LVEF) <30%) using a selective IgG3 adsorption column. All patients had anti-beta1-adrenergic and/or M2-muscarinic autoantibodies before IA, and all LVEF were measured on radionuclide ventriculography. CD-Abs were measured before and after IA, and patient status was blinded until all measurements were collected. Treatment was defined as complete when CD-Abs status changed from positive to negative after IA. Other instances were defined as incomplete. Six-min walk test results and brain natriuretic peptide levels improved significantly after IA (P<0.01). The increase in LVEF 3 months after IA was significantly greater after complete treatment in comparison to the incomplete treatment group (19+/-8-29+/-9% vs 18+/-9-17+/-8%, P<0.01). Cardiac insufficiency events were also more frequent in the incomplete treatment group.

CONCLUSIONS

Complete elimination of CD-Abs with apheresis may be related to improved cardiac function in the treatment of heart failure.

摘要

背景

心肌抑制 IgG3 自身抗体 (CD-Abs) 可通过血浆分离术靶向治疗。通过对免疫吸附 (IA) 前后 CD-Abs 的盲测,比较了完全清除 CD-Abs 和未完全清除 CD-Abs 的患者的心脏功能。

方法和结果

采用选择性 IgG3 吸附柱从 18 例心力衰竭患者 (纽约心脏协会分级 3 或 4 级,左心室射血分数 (LVEF) <30%) 中完全清除自身抗体。所有患者在 IA 前均存在抗β1-肾上腺素能和/或 M2-毒蕈碱自身抗体,所有 LVEF 均通过放射性核素心室造影术测量。IA 前后均测量 CD-Abs,患者状态在所有测量完成前保持盲态。当 IA 后 CD-Abs 状态从阳性变为阴性时,将治疗定义为完全清除。其他情况定义为不完全清除。IA 后 6 分钟步行试验结果和脑钠肽水平显著改善 (P<0.01)。与不完全清除治疗组相比,完全清除治疗组 3 个月后 LVEF 的增加更显著 (19+/-8%-29+/-9%比 18+/-9%-17+/-8%,P<0.01)。不完全清除治疗组也更频繁发生心力衰竭事件。

结论

用血浆分离术完全清除 CD-Abs 可能与心力衰竭治疗中心脏功能的改善有关。

相似文献

1
Complete elimination of cardiodepressant IgG3 autoantibodies by immunoadsorption in patients with severe heart failure.免疫吸附法清除重症心力衰竭患者心肌抑制 IgG3 自身抗体。
Circ J. 2010 Jul;74(7):1372-8. doi: 10.1253/circj.cj-09-0748. Epub 2010 May 22.
2
Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β-Adrenergic Receptors.收缩性心力衰竭合并β-肾上腺素能受体自身抗体患者的心肌恢复情况
J Am Coll Cardiol. 2017 Feb 28;69(8):968-977. doi: 10.1016/j.jacc.2016.11.067.
3
Autoantigen estimation and simple screening assay against cardiodepressant autoantibodies in patients with dilated cardiomyopathy.扩张型心肌病患者中心脏抑制性自身抗体的自身抗原评估及简易筛查试验
Ther Apher Dial. 2008 Apr;12(2):109-16. doi: 10.1111/j.1744-9987.2008.00555.x.
4
Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption.免疫球蛋白G3亚类在扩张型心肌病中的作用:蛋白A免疫吸附的结果
Am Heart J. 2005 Oct;150(4):729-36. doi: 10.1016/j.ahj.2004.11.002.
5
Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry.免疫吸附及后续免疫球蛋白替代治疗扩张型心肌病患者的疗效:前瞻性观察性巴特贝卡登记研究结果
J Cardiol. 2017 Feb;69(2):409-416. doi: 10.1016/j.jjcc.2016.07.014. Epub 2016 Nov 24.
6
Ig apheresis for the treatment of severe DCM patients.免疫球蛋白单采术用于治疗重度扩张型心肌病患者。
Atheroscler Suppl. 2013 Jan;14(1):213-8. doi: 10.1016/j.atherosclerosissup.2012.10.028.
7
Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.免疫球蛋白G-3亚类自身抗体在扩张型心肌病患者心脏功能障碍中的潜在作用。
Circulation. 2002 Nov 5;106(19):2448-53. doi: 10.1161/01.cir.0000036746.49449.64.
8
The effect of a repeated immunoadsorption in patients with dilated cardiomyopathy after recurrence of severe heart failure symptoms.严重心力衰竭症状复发后,重复免疫吸附对扩张型心肌病患者的影响。
J Clin Apher. 2015 Aug;30(4):217-23. doi: 10.1002/jca.21364. Epub 2014 Oct 27.
9
Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.蛋白A免疫吸附对晚期慢性扩张型心肌病患者的影响。
J Clin Apher. 2009;24(4):141-9. doi: 10.1002/jca.20204.
10
Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.免疫吸附可改善患有与糖尿病相关的非缺血性扩张型心肌病的移植候选者的心脏功能。
Atheroscler Suppl. 2015 May;18:124-33. doi: 10.1016/j.atherosclerosissup.2015.02.023.

引用本文的文献

1
Autoimmunity in Cardiomyopathy-Induced Heart Failure and Cardiac Autoantibody Removal by Immunoadsorption.心肌病所致心力衰竭中的自身免疫及免疫吸附去除心脏自身抗体
J Clin Med. 2025 Feb 1;14(3):947. doi: 10.3390/jcm14030947.
2
β Adrenergic Receptor Autoantibodies and IgG Subclasses: Current Status and Unsolved Issues.β肾上腺素能受体自身抗体与IgG亚类:现状与未解决的问题
J Cardiovasc Dev Dis. 2023 Sep 10;10(9):390. doi: 10.3390/jcdd10090390.
3
The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman  Pinschers of efficacy and outcomes.
用于治疗扩张型心肌病的适配体BC 007:在杜宾犬中的疗效和结果评估
ESC Heart Fail. 2020 Jun;7(3):844-855. doi: 10.1002/ehf2.12628. Epub 2020 Mar 24.
4
Autoantibody against β-adrenoceptor promotes the differentiation of natural regulatory T cells from activated CD4 T cells by up-regulating AMPK-mediated fatty acid oxidation.β-肾上腺素能受体自身抗体通过上调 AMPK 介导的脂肪酸氧化促进激活的 CD4 T 细胞中天然调节性 T 细胞的分化。
Cell Death Dis. 2019 Feb 15;10(3):158. doi: 10.1038/s41419-018-1209-2.
5
Decreased autophagy induced by β-adrenoceptor autoantibodies contributes to cardiomyocyte apoptosis.β-肾上腺素能受体自身抗体诱导的自噬减少导致心肌细胞凋亡。
Cell Death Dis. 2018 Mar 14;9(3):406. doi: 10.1038/s41419-018-0445-9.
6
Plasma exchange for the patients with dilated cardiomyopathy in children is safe and effective in improving both cardiac function and daily activities.血浆置换对于儿童扩张型心肌病患者在改善心脏功能和日常活动方面是安全且有效的。
J Artif Organs. 2017 Sep;20(3):236-243. doi: 10.1007/s10047-017-0956-7. Epub 2017 Apr 5.
7
Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β-Adrenergic Receptors.收缩性心力衰竭合并β-肾上腺素能受体自身抗体患者的心肌恢复情况
J Am Coll Cardiol. 2017 Feb 28;69(8):968-977. doi: 10.1016/j.jacc.2016.11.067.
8
Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.β受体阻滞剂时代慢性收缩性心力衰竭患者中特异性抗β1肾上腺素能受体自身抗体与不良临床结局:免疫球蛋白G3亚类的重要性
J Card Fail. 2016 Jun;22(6):417-22. doi: 10.1016/j.cardfail.2016.03.005. Epub 2016 Mar 17.
9
Autoimmunity Against the Heart and Cardiac Myosin in Children With Myocarditis.心肌炎患儿中针对心脏和心肌肌球蛋白的自身免疫反应
J Card Fail. 2016 Jul;22(7):520-8. doi: 10.1016/j.cardfail.2016.02.009. Epub 2016 Mar 3.
10
Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column-A prospective, multicenter, randomized, within-patient and parallel-group comparative study to evaluate efficacy and safety.使用色氨酸柱的扩张型心肌病免疫吸附疗法——一项评估疗效和安全性的前瞻性、多中心、随机、患者自身平行组对照研究
J Clin Apher. 2016 Dec;31(6):535-544. doi: 10.1002/jca.21446. Epub 2016 Jan 23.